SciTech Development LLC
2-10
SciTech Development LLC
Grosse Pointe Farms, Michigan, United States
2-10
Tell me more about SciTech Development LLC?
Want to view all employees of this company? Start for free trial.
view 7 associated members
SciTech Development LLC In Short
SciTech Development LLC is a chemical manufacturing company based in Grosse Pointe Farms, Michigan, with 7 employees. Specializing in advanced cancer treatment, the company offers a revolutionary new drug delivery platform and lead cancer drug candidate ST-001 nanoFenretinide. SDP aims to revolutionize the safe and promising, yet challenged drugs to kill cancer and empower scientists to engineer, develop, and patent new drugs. The company is currently Phase 1, clinical trial ready for the treatment of lymphoma with a rapid path to commercialization.
...See MoreCompany Description of SciTech Development LLC
SciTech Development is a Specialty Pharmaceutical Company dedicated to advancing breakthrough cancer treatments. SciTech’s innovations and pipeline will impact our mission to develop cost-effective therapeutics that deliver transformative clinical outcomes. SCITECH DEVELOPMENT LLC Introducing Our Revolutionary New Drug Delivery Platform (SDP) and Lead Cancer Drug Candidate ST-001 nanoFenretinide. ● Our proprietary Drug Delivery Platform, called SDP, has enormous potential to develop and deliver new and better drugs for incurable cancers. ● ST-001-nanoFenretinide is our first, patented drug, that combines SDP and the drug fenretinide as a broadly applicable anticancer drug. ● Fenretinide presents a low-risk scenario as it has been shown to be safe and effective in both children and adults in previous clinical trials. ● ST-001 is clinical trial ready! OUR GOAL Our immediate goal is to commercialize ST-001 and develop strategic partnerships with companies in the pharmaceutical industry who are looking to expand their existing drug portfolio in oncology, target new diseases, or develop combination drug therapies. OUR HIGHLIGHTS AND ACHIEVEMENTS • IND for T-Cell Lymphomas approved by the FDA • FDA approved Phase 1a/b (equivalent to traditional Phase 1 & 2) clinical trial plan • IRB Approved by Rush University Medical Center to start clinical trials • Orphan Drug Designation granted for several T-cell lymphomas • SDP can be used to solve bioavailability and delivery issues in many other drugs • SDP has potential application for treating additional cancers and other diseases • ST-001 has potential use as a companion therapeutic with other already approved drugs • Affordable treatment cost to patients and for payors
...See More281 Kercheval Avenue , Grosse Pointe Farms, MI, 48236, US
+1 3*******
7
Similar Companies
What does SciTech Development LLC offer?
SciTech Development LLC specializes in developing a revolutionary Drug Delivery Platform (SDP) to deliver safe and promising drugs to kill cancer. Their lead cancer drug candidate, ST-001 nanoFenretinide, combines SDP and fenretinide to create an affordable cancer treatment. The company aims to address the urgent need for effective cancer medicines at an affordable cost
Jobs
Investment
Company insights
Org Chart
Key People
Earle Holsapple III
Chief Executive Officer
Louis M Scarmoutzos, Ph.D.
Chief Operations Officer
Lou Scarmoutzos
Chief Operating Officer
David Schaffer
Head Of Investor Relations
Ali Moiin, M.D.
Head Of Clinical Affairs
Michael Burns
Head Of Product Development
Frequently asked questions
SciTech Development LLC's headquarter is located at 281 Kercheval Avenue , Grosse Pointe Farms, MI, 48236, US
SciTech Development LLC has 7 employees
SciTech Development LLC's phone number is +1 3*******
SciTech Development LLC's website is https://www.******.***
SciTech Development LLC is in the industry of: Pharmaceutical Manufacturing
SciTech Development LLC's similar companies are: BDM Collective,BioConsult4.0,Breadless,Doc. On Journey